Santarus_logo
Santarus to Launch Novel Type 2 Diabetes Drug CYCLOSET
San Diego based Santarus, a biopharmaceutical company, announced the commercial U.S. launch of CYCLOSET (bromocriptine mesylate) tablets. CYCLOSET is a FDA approved prescription drug to improve glycemic control in adults with type 2 diabetes mellitus both as monotherapy and in combination with other oral antidiabetic agents...
Carb Loading – A Diabetic’s Dilemma
Eating is as important as training for a runner’s ability to perform. This is something I had to learn the hard way. When I trained for my second marathon,…
Bristol-Myers
Bristol-Myers Squibb Commits $100 Million to Fighting Type 2 Diabetes in the US
The Bristol-Myers Squibb Foundation announced the Together on Diabetes initiative, the largest corporate philanthropic commitment to fighting type 2 diabetes in the United States to date. The $100 million, five year initiative aims to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor’s office. Together on Diabetes is the Foundation’s first large-scale diabetes initiative. Working with a wide variety of...
JDRF New Logo
New Recommendations For Artificial Pancreas Development
A panel of experts convened by the FDA and NIH to try to advance research and development of the artificial pancreas put forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations. The experts are in agreement that even with the advanced treatments available today...
Thinking about Continuous Glucose Monitoring
Deciding to postpone yesterday’s run to this morning, following my hypoglycemic episode was the right thing to do. I woke up at 5:00am this morning…